SYT up +0.90% percent right now. $SYT High is at 63.20 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
SYT up +0.90% percent right now. $SYT High is at 63.20 and the Low 62.92 with current volume of 75,125.

Recent News posted below.

SYT Syngenta Ag Recent Headline News

Voters Say "Heck No, Don't Label GMO!"
Rich Duprey, The Motley Fool - Motley Fool - Tue Nov 11, 11:30AM CST
Voters in two states rejected ballot initiatives last week that would have required foods containing genetically modified organisms to carry labels identifying the presence of such ingredients, handing big wins to food manufacturers like General...
SYT: 63.14 (+0.77), MON: 118.18 (+1.29), DD: 70.88 (+0.15), KRFT: 57.78 (-0.13), GIS: 50.92 (+0.05), DOW: 49.51 (+0.03), PEP: 96.79 (-0.18)

Shares of SYT Down 17.3% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Nov 10, 12:59PM CST
SmarTrend identified a Downtrend for Syngenta (NYSE:SYT) on June 11th, 2014 at $75.25. In approximately 5 months, Syngenta has returned 17.33% as of today's recent price of $62.21.
SYT: 63.14 (+0.77)

Downgrade Alert for Syngenta (SYT)
Comtex SmarTrend(R) - Mon Nov 10, 7:56AM CST
Syngenta (NYSE:SYT) was downgraded from Overweight to Neutral at HSBC today. The stock closed yesterday at $62.81 on volume of 281,000 shares, below average daily volume of 513,000. Over the past year, Syngenta has traded in a range of $58.72 to $80.25 and closed yesterday at $62.81, 7% above that low. Over the last five market days, the 200-day moving average (MA) has gone down 0.5% while the 50-day MA has declined 1.6%.
SYT: 63.14 (+0.77)

Dumpster Diving The Dividend Contenders
Eric Landis - at Seeking Alpha - Fri Nov 07, 2:59PM CST

SYT: 63.14 (+0.77), CRR: 50.38 (-0.07), UTX: 108.17 (-0.83), DE: 88.52 (-0.02), CNQ: 36.31 (+0.66)

Heninger Garrison Davis Files GMO Corn Class Action Lawsuit Against Syngenta
PRWeb - Fri Nov 07, 7:03AM CST
Heninger Garrison Davis, recognized as one of the nation's leading litigation firms, has filed a class action lawsuit on behalf of corn and DDGS exporters, distributors and farmers against Syngenta over sales of the GMO corn seed Agrisure Viptera MIR 162. MIR 162 is not approved for sale in China. The Foxtrap Planting Co., LLC. vs. Syngenta AG. (No. 3:14-cv-858-TSL-RHW. So. Dist. Miss.) lawsuit claims that Syngenta knew, or should have known, that releasing MIR 162 into the marketplace would lead to the contamination of U.S. corn shipments and prevent U.S. corn from being sold to major export markets such as China. The class action court documents allege that the resulting harm to exporters, distributors and farmers is a significant reduction in revenue due to falling grain prices, governmentally destroyed crops, and a lack of confidence in U.S. sourced corn.
SYT: 63.14 (+0.77)

18.2% Return Seen to Date on SmarTrend Syngenta Call (SYT)
Comtex SmarTrend(R) - Mon Nov 03, 9:52AM CST
SmarTrend identified a Downtrend for Syngenta (NYSE:SYT) on June 11th, 2014 at $75.25. In approximately 5 months, Syngenta has returned 18.25% as of today's recent price of $61.52.
SYT: 63.14 (+0.77)

Syngenta Down 19.0% Since SmarTrend Downtrend Call (SYT)
Comtex SmarTrend(R) - Mon Oct 27, 9:21AM CDT
SmarTrend identified a Downtrend for Syngenta (NYSE:SYT) on June 11th, 2014 at $75.25. In approximately 5 months, Syngenta has returned 19.03% as of today's recent price of $60.93.
SYT: 63.14 (+0.77)

People Really Hate Monsanto, Its Latest Move Shows It Couldn't Care Less
Rich Duprey, The Motley Fool - Motley Fool - Sat Oct 25, 8:50AM CDT
The biotech people love to hate may generate even more antipathy by pushing ahead with chemically treated seeds that don't help farmers increase yields -- and may kill bees and birds. Photo: Flickr via Donna Cleveland. Biotech giant Monsanto ...
NLSN: 43.01 (-0.01), SYT: 63.14 (+0.77), MON: 118.18 (+1.29), DD: 70.88 (+0.15), BP: 41.77 (-0.09), BAC: 17.34 (-0.03), DOW: 49.51 (+0.03)

Agricultural Biotechnology - 2014 Global Strategic Business Report
M2 - Thu Oct 23, 3:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dkq2ds/agricultural) has announced the addition of the "Agricultural Biotechnology - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. The regions analyzed in the report for GM crops include the following: US, Canada, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 76 companies including many key and niche players. This report analyzes the worldwide markets for Agricultural Biotechnology in US$ Million by the following Groups/Segments: - Transgenic Seeds/Crops (Soybean, Corn, Cotton, & Others) - Biopesticides. Key Topics Covered: . Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Issues & Trends 3. Transgenic Crops - An Overview 4. Agricultural Biotechnology In Developing Regions 5. Agricultural Biotechnology - An Overview 6. Regulatory Environment 7. Recent Industry Activity 8. Product Introductions/Innovations 9. Focus On Select Global Players 10. Global Market Perspective III. Market 1. The United States 2. Canada 3. Asia-Pacific 4. Latin America 5. Japan 6. Europe 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 76 (including Divisions/Subsidiaries - 89) - The United States (41) - Canada (5) - Japan (2) - Europe (18) - - France (4) - - Germany (7) - - The United Kingdom (1) - - Italy (2) - - Rest of Europe (4) - Asia-Pacific (Excluding Japan) (19) - Middle East (4) Companies Mentioned - ADAMA Agricultural Solutions Ltd. - BASF SE - Bayer CropScience AG - Certis USA, LLC - Dow AgroSciences, LLC - Mycogen Seeds - DuPont Pioneer - Monsanto Company - Performance Plants, Inc. - Syngenta AG For more information visit http://www.researchandmarkets.com/research/dk...ricultural
SYT: 63.14 (+0.77), MON: 118.18 (+1.29)

Downtrend Call Working As Syngenta Stock Falls 19.3% (SYT)
Comtex SmarTrend(R) - Fri Oct 17, 5:02PM CDT
SmarTrend identified a Downtrend for Syngenta (NYSE:SYT) on June 11th, 2014 at $75.25. In approximately 4 months, Syngenta has returned 19.35% as of today's recent price of $60.69.
SYT: 63.14 (+0.77)

Syngenta's Q3 Sales Rise Y/Y, 2014 Sales Growth Maintained - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 17, 9:59AM CDT
Syngenta AG (SYT), after completing third-quarter 2014, has maintained its full year aggregated sales growth rate of 6%.
BG: 89.09 (+0.34), SYT: 63.14 (+0.77), LMNR: 25.54 (+0.03), ANDE: 54.61 (-0.16)

Low Commodity Prices Create Buying Opportunities In The Agricultural Sector
Seeking Early Retirement - at Seeking Alpha - Thu Oct 16, 2:17PM CDT

CNHI: 8.12 (unch), MON: 118.18 (+1.29), UPL: 23.77 (+0.07), AGCO: 45.19 (-0.05), POT: 33.43 (+0.26), FMC: 56.81 (+0.02), SYT: 63.14 (+0.77), CF: 267.09 (+12.69), BHP: 58.97 (-0.26), AGU: 98.47 (+0.59), DE: 88.52 (-0.02), MOS: 44.79 (+0.68)

Syngenta sales lifted by Latin America, Asia-Pacific
Seeking Alpha - at Seeking Alpha - Thu Oct 16, 7:17AM CDT

SYT: 63.14 (+0.77)

Syngenta Shares Down 20.2% Since SmarTrend's Sell Call (SYT)
Comtex SmarTrend(R) - Fri Oct 10, 11:11AM CDT
SmarTrend identified a Downtrend for Syngenta (NYSE:SYT) on June 11th, 2014 at $75.25. In approximately 4 months, Syngenta has returned 20.20% as of today's recent price of $60.05.
SYT: 63.14 (+0.77)

Syngenta Lawsuit for GMO Corn Seed Page Launched by The Oliver Law Group P.C. to Provide Info On Litigation Involving Syngenta Attempt to Commercialize GMO Corn Seed
PRWeb - Sat Oct 04, 2:01AM CDT
The Oliver Law Group P.C. is pleased to announce that it has launched a Syngenta lawsuit for GMO Corn Seed web page to provide the public with information about the litigation surrounding Agrisure Viptera, a variety of genetically modified corn seed which has not been approved for sale in China. According to a recent report from The Wall Street Journal, China has rejected numerous shipments of U.S. corn that contain the Agrisure Viptera variety, which resulted in an 85% reduction of such shipments in the first seven months of 2014. The Syngenta matter has also contributed to a nearly-60% reduction in corn prices from their 2012 peak. (wsj.com/articles/cargill-sues-syngenta-says-gmo-seed-sales-hurt-u-s-corn-exports-to-china-1410542784, The Wall Street Journal, September 12, 2014)
SYT: 63.14 (+0.77)

SmarTrend Watching for Potential Rebound in Shares of Syngenta After 1.36% Loss
Comtex SmarTrend(R) - Fri Oct 03, 4:35PM CDT
Syngenta (NYSE:SYT) traded in a range yesterday that spanned from a low of $60.42 to a high of $61.04. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $61.24 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SYT: 63.14 (+0.77)

UPRO, NJ, CEL, SYT, HUN, CALD Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Oct 03, 4:23AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ProShares UltraPro S&P 500 (NYSE:UPRO), Nidec Corp (NYSE:NJ), Columbus Energy Ltd (NYSE:CEL), Syngenta AG (NYSE:SYT), Huntsman Corp (NYSE:HUN), Callidus Software Inc (NASDAQ:CALD) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
CEL: 9.71 (-0.12), UPRO: 128.88 (+0.21), SYT: 63.14 (+0.77), NJ: 16.02 (+0.15), CALD: 15.98 (+0.11), HUN: 25.16 (+0.23)

Global Acaricides Market Outlook 2019 - Key Vendors are BASF SE, Arysta LifeScience, Bayer AG, DuPont & FMC Corporation
M2 - Tue Sep 30, 9:35AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9mdhbk/acaricides_market) has announced the addition of the "Acaricides Market by Type, by Application, by Mode of Action & Geography - Trends & Forecasts to 2019" report to their offering. The global acaricides market is estimated to be valued at $275.1 million by 2019, at a projected CAGR of 5.2% from 2014 Acaricides are chemicals that are manufactured and used for controlling the spread of arthropod pests. These pests, if allowed to spread, cause huge losses to agricultural crops and also infect various animals in the animal husbandry industry. There are numbers of acaricides available, which have different concentrations of various chemicals like chlorine, phosphorus, zinc, and tin. Acaricides have toxic effects too, due to which natural products like neem, clove, and spoiled corns, are also being used for the production of acaricides. These natural acaricides tend to be less toxic. The Asia-Pacific region is estimated to be the largest consumer of acaricides in the world, followed by Europe. China is estimated as the largest market in the Asia-Pacific, having captured around 44% of the total market in the region, in 2013. This market is growing steadily due to an increase in the usage of crop protection chemicals to control the spread of ticks and mite-borne diseases. The demand-driving factors of this market are developments in the crop protection industry and the rise in demand for meat and dairy products. The restraining factors are the regulatory restrictions in some countries and the rising cost of acaricides. Key participants in the acaricides market are BASF SE (Germany), Arysta LifeScience (Japan), Bayer AG (Germany), DuPont (U.S.), and FMC Corporation (U.S.). The acaricides market is witnessing rapid development in the areas of new product launches, with a focus on increasing the availability of various acaricides in the market and also on increasing their global market share. Scope Of The Report By type - Organochlorine - Organophosphorus - Natural - Others By application - Agriculture - Animal Husbandry - Industrial - Others By mode of application - Spray - Dipping vat - Hand dressing - Others Companies Mentioned - Arysta Lifescience - BASF SE - Bayer AG - Chemtura Corporation - Dupont - FMC Corporation - Merck & Co., Inc. - Nissan Chemical Industries, Ltd. - Syngenta AG - The Dow Chemical Company For more information visit http://www.researchandmarkets.com/research/9m...des_market
SYT: 63.14 (+0.77), MRK: 59.45 (+0.64), FMC: 56.82 (+0.03), CHMT: 23.50 (+0.14)

Syngenta's COO to retire: Jon Parr named as new COO
M2 - Mon Sep 29, 6:04AM CDT
Crop development company Syngenta AG (Xetra:SVJ.DE)(VTX:SYNN.VX)(NYSE:ST) announced on Monday that John Atkin, chief operating officer, will retire from the company at the end of 2014.
ST: 49.12 (-0.15), SYT: 63.14 (+0.77)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 147

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
Early Dog Guarding Signs Matter Before a Sudden Growl

Updated Category News Views 92

A bowl, a chewed-up toy, or a patch of couch can turn tense in a heartbeat. That is why the useful part of Brian Manning's guidance is not some fantasy of making every dog endlessly tolerant; it is learning to notice discomfort while there is still room to back off safely. For anybody watching the pet-care and behavior-training field, this is the kind of plainspoken...

Continue Reading
Humanoid Robots Need Results Before 2035 Hype Peaks

Updated Category News Views 245

A robot climbing stairs is neat; a robot finishing Tuesday’s shift is the investment case. The latest humanoid robotics forecast puts the global market at $3.07 billion in 2026, up from $2.26 billion in 2025, and projects $47.49 billion by 2035. That is a 35.59% compound annual growth rate, the kind of number that makes investors sit up straight. It also demands a...

Continue Reading
Health In Tech Brings a Tech Veteran Onto Its Board

Updated Category News Views 115

Board appointments rarely make the cash register ring, but they can tell you where management thinks the next bruises are coming from. Health In Tech has added Tim Cortes as an independent director, put him in charge of the Compensation Committee, and placed him on both the Audit and Nominating and Corporate Governance Committees. For an AI-enabled insurance technology...

Continue Reading
Misunderstood Brands Bets Small Cans Can Scale Growth

Updated Category News Views 168

A tiny cocktail can is a brutal little test of whether a spirits brand has legs. Misunderstood Brands is putting four 100mL offerings on the shelf just as its Wegmans distribution expands across the East Coast, and that combination matters more than another glossy flavor announcement. The company is trying to turn products people discovered in bars and restaurants into...

Continue Reading
Clarivate's 2026 Research List Carries a Trust Test

Updated Category News Views 254

Seven thousand ninety awards can look like a victory lap until you remember how easily raw citation counts can be gamed. Clarivate’s 2026 Highly Cited Researchers list is more interesting for its insistence on screening than for the familiar names at the top. In a research world where publication volume, self-citation and paper mills have made plenty of people...

Continue Reading
Excel Treatment Center Adds ART Trauma Therapy Option

Updated Category News Views 158

Trauma rarely arrives at an addiction program wearing a name tag. Excel Treatment Center in Dover, New Jersey, is responding to that uncomfortable reality by adding Accelerated Resolution Therapy® (ART) to the individual, group, and family therapy already available to its clients. The center says its therapists have completed ART training, and the approach is now part of...

Continue Reading
Peñoles Locks In Solar Storage for Northern Mine Loads

Updated Category News Views 54

A mine never sleeps, which is why the battery matters more than the solar-panel headline. Peñoles has signed a 20-year power-supply agreement with Atlas Renewable Energy for a Coahuila project combining 269 MWp of solar generation with battery storage. The project is slated to begin operating in the first half of 2029 and is expected to provide roughly 550 GWh a year to...

Continue Reading
Anycubic Pushes Toward a Smoother 3D Printing Ecosystem

Updated Category News Views 68

Friction Is the Enemy in Consumer 3D Printing A printer that makes a beautiful object only after three failed attempts is not a consumer product; it is a weekend argument with plastic. That is the useful lens for Anycubic's Formnext 2026 showing in Frankfurt on November 18. The company is not merely rolling out FDM and resin machines at Booth F01 in Hall 12.0. It is...

Continue Reading
Workday’s EU Cloud Move Raises the Sovereignty Bar Again

Updated Category News Views 124

Europe’s sovereignty squeeze just got a lot more concrete for Workday. The company is taking its EU Sovereign Cloud beyond the usual data-residency talking points by planning an Ireland-based operating company, European leadership, and governance intended to keep decisions on the service and customer data inside Europe. For a platform sitting underneath payroll, HR...

Continue Reading

Top 5 Most Recently Viewed Articles

Hepsiburada's Impressive Q3 2025 Performance Review

Updated Category News Views 281

Hepsiburada Reports Significant Gains in Q3 2025 Hepsiburada, officially known as D-MARKET Electronic Services & Trading (NASDAQ: HEPS), has unveiled robust financial results for the third quarter of 2025. The Turkish e-commerce giant reported an impressive increase in gross merchandise value (GMV) and revenue, highlighting the company's operational resilience in a...

Continue Reading
Fulcrum Therapeutics Faces Challenges Amid Sickle Cell Trials

Updated Category News Views 212

Market Moves and Stock Reactions So, let’s get straight to the meat of it. Fulcrum Therapeutics Inc. (NASDAQ:FULC) took a nosedive recently—down about 10%—right after they dropped the latest news on their Phase 1b trial for pociredir aimed at treating sickle cell disease. Stock fell to around $9.80, and honestly, if you're still holding shares, well, it's time to...

Continue Reading
SBM Offshore's Share Repurchase Program Insights and Updates

Updated Category News Views 215

Overview of SBM Offshore’s Share Repurchase Program SBM Offshore has recently conducted a significant share repurchase program amounting to EUR141 million (approximately US$150 million). This initiative began on April 24, 2025, and aims to reduce share capital while also supporting management and employee share programs. The program has been designed to both enhance...

Continue Reading
Plymouth Industrial REIT Responds to Acquisition Proposal

Updated Category News Views 212

Plymouth Industrial REIT Receives Unsolicited Acquisition Proposal Plymouth Industrial REIT, Inc. (NYSE: PLYM), a leader in the industrial real estate sector, recently attracted attention with an unsolicited and non-binding acquisition proposal. This proposal comes from Sixth Street Partners, LLC, and suggests a price of $24.10 per share for all outstanding shares of the...

Continue Reading
Middlefield Canadian Income PCC AGM Results Breakdown

Updated Category News Views 230

Overview of the AGM Results for Middlefield Canadian Income PCC Middlefield Canadian Income PCC (the "Company") and Middlefield Canadian Income - GBP PC (the "Cell") have recently concluded their annual general meeting, a significant event that spotlighted the Company's journey and future direction. Conducted with transparency and diligence, this meeting has underscored...

Continue Reading